Conestoga Capital Advisors LLC Buys 34,235 Shares of Exponent Inc. (EXPO)
Conestoga Capital Advisors LLC increased its stake in Exponent Inc. (NASDAQ:EXPO) by 6.2% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 582,852 shares of the company’s stock after buying an additional 34,235 shares during the period. Exponent accounts for about 2.0% of Conestoga Capital Advisors LLC’s holdings, making the stock its 24th largest position. Conestoga Capital Advisors LLC owned about 2.24% of Exponent worth $29,760,000 at the end of the most recent reporting period.
A number of other institutional investors also recently bought and sold shares of EXPO. GW&K Investment Management LLC raised its stake in shares of Exponent by 17.2% in the second quarter. GW&K Investment Management LLC now owns 316,076 shares of the company’s stock worth $18,462,000 after buying an additional 46,418 shares in the last quarter. California Public Employees Retirement System raised its stake in shares of Exponent by 2.1% in the second quarter. California Public Employees Retirement System now owns 107,800 shares of the company’s stock worth $6,297,000 after buying an additional 2,200 shares in the last quarter. Goldman Sachs Group Inc. raised its stake in shares of Exponent by 84.4% in the first quarter. Goldman Sachs Group Inc. now owns 23,143 shares of the company’s stock worth $1,181,000 after buying an additional 10,594 shares in the last quarter. Nordea Investment Management AB purchased a new position in Exponent during the second quarter worth approximately $684,000. Finally, Swiss National Bank boosted its position in Exponent by 1.2% in the second quarter. Swiss National Bank now owns 43,600 shares of the company’s stock worth $2,547,000 after buying an additional 500 shares during the last quarter. Institutional investors and hedge funds own 92.79% of the company’s stock.
Shares of Exponent Inc. (NASDAQ:EXPO) traded up 0.57% on Monday, reaching $61.30. The company’s stock had a trading volume of 115,474 shares. The firm has a market capitalization of $1.57 billion, a PE ratio of 35.43 and a beta of 0.65. Exponent Inc. has a one year low of $44.82 and a one year high of $63.00. The firm has a 50-day moving average price of $55.34 and a 200 day moving average price of $53.35.
Exponent (NASDAQ:EXPO) last announced its earnings results on Wednesday, October 19th. The company reported $0.42 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.34 by $0.08. The business had revenue of $77.60 million for the quarter, compared to analysts’ expectations of $74.46 million. Exponent had a return on equity of 15.72% and a net margin of 15.06%. The business’s revenue for the quarter was down .4% on a year-over-year basis. During the same quarter last year, the firm earned $0.43 EPS. On average, analysts anticipate that Exponent Inc. will post $1.70 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Friday, December 23rd. Shareholders of record on Friday, December 2nd will be given a dividend of $0.18 per share. The ex-dividend date is Wednesday, November 30th. This represents a $0.72 annualized dividend and a yield of 1.17%. Exponent’s dividend payout ratio (DPR) is presently 41.86%.
A number of research analysts have recently commented on the company. Zacks Investment Research upgraded Exponent from a “hold” rating to a “strong-buy” rating and set a $66.00 target price for the company in a research note on Monday, October 24th. Cantor Fitzgerald set a $57.00 price objective on Exponent and gave the company a “buy” rating in a research note on Thursday, October 20th.
In other news, Director Michael R. Gaulke sold 8,750 shares of the stock in a transaction on Thursday, October 20th. The stock was sold at an average price of $55.14, for a total transaction of $482,475.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Michael R. Gaulke sold 4,000 shares of the stock in a transaction on Monday, October 24th. The shares were sold at an average price of $57.06, for a total value of $228,240.00. The disclosure for this sale can be found here. Company insiders own 3.50% of the company’s stock.
Exponent, Inc, along with its subsidiaries, is a science and engineering consulting company. The Company operates through two segments: Engineering and Other Scientific, and Environmental and Health. Its Engineering and Other Scientific segment includes biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, electrical engineering and computer science, engineering management consulting, human factors, industrial structures, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, technology development, thermal sciences and vehicle analysis services.
Receive News & Stock Ratings for Exponent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent Inc. and related stocks with our FREE daily email newsletter.